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ARTICLES

Process Evaluation of a Treatment Program for Mood
and Anxiety Disorders Among Emerging Adults:
Preentry Factors, Engagement, and Outcomes
Elizabeth Osuch, M.D., Evelyn Vingilis, Ph.D., Carolyn Summerhurst, M.S.W., Jazzmin Demy, B.A.Sc.,
Michael Wammes, M.S., Justin Arcaro, M.S.

Objective: Effective mental health services for emerging
adults are needed. This work evaluated the logic model of
one such program and assessed participation and mediumterm outcomes.
Methods: Baseline data were collected from 398 emerging adults attending an intake appointment at a mood and
anxiety disorders treatment program in Canada for persons
ages 16–25. Questionnaires about demographic characteristics, prior help seeking, symptoms, functional impairment, and health satisfaction were completed at baseline
and at follow-up, approximately 2 to 10 months later
(mean=6 months), depending on participants’ availability
and willingness. Program satisfaction was also assessed.
Preentry characteristics and disengagement were evaluated. Repeated-measures analyses were used to evaluate
outcomes.
Results: The program did not require physician referral;
however, emerging adults who contacted the program had

Research indicates that 15.5% of disability-adjusted life
years (DALYs) worldwide arise from illnesses that begin
when individuals are between the ages of 10 and 24 (1).
The largest contributors to DALYs are neuropsychiatric
disorders, at 45% of the total (1). However, treatment
gaps of over 50% exist for such conditions (2). The World
Health Organization concluded that the focus should be
on emerging adulthood for prevention of chronic neuropsychiatric illnesses to decrease worldwide disability (1).
Mood and anxiety disorders have a heavy symptom burden
(3), with the ﬁrst and second highest DALYs among psychiatric disorders, respectively (4). In North America, lifetime prevalence rates are approximately 29% for anxiety
disorders and 21% for mood disorders (5), and at least 75% of
these disorders begin before age 25. These disorders have
a high probability of recurrence and can become chronic
(6, 7). Among individuals with chronic depression, 15% die
by suicide (8).
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extensive prior help seeking: 73% had seen a family doctor
and 32% had visited an emergency department. Among
370 individuals for whom full intake data were available,
scores indicated moderate depression, moderate anxiety,
and low satisfaction with quality of health. They reported
either not functioning or underfunctioning for a mean of
4.3 days per week. Follow-up data indicated signiﬁcant
improvement on all measures, including clinically signiﬁcant improvement in both depression and functioning. Patient satisfaction was high, and quality of health improved
signiﬁcantly.
Conclusions: Results indicate that the model studied, which
emphasizes early-stage intervention for mood and anxiety
disorders among emerging adults, was associated with statistical and clinical improvement at intermediate follow-up.
Outputs and medium-term outcomes of the model were
satisﬁed.
Psychiatric Services 2019; 70:211–218; doi: 10.1176/appi.ps.201800219

In our previous process evaluation of a program for mood
and anxiety disorders among emerging adults, the First
Episode Mood and Anxiety Program (FEMAP) (9), we described the outputs of the model (10, 11). The study reported

HIGHLIGHTS

• Emerging adults coming to a specialized mental health
care program that allowed self-referral for affective
disorders had already tried numerous sources of help,
including school and primary care services.

• Emerging adults who stayed engaged in treatment were
more ill than those who disengaged early.

• Personalized treatment in the early stages of affective
illnesses reduces symptoms and improves functioning
as measured at intermediate-term follow-up (average
6 months); it was rated positively by users.

ps.psychiatryonline.org 211

PROCESS EVALUATION OF A TREATMENT PROGRAM FOR MOOD AND ANXIETY DISORDERS

FIGURE 1. Logic model for process evaluation of the First Episode Mood and Anxiety Program (FEMAP)
Activities

Outputs

Phase I
Intake process allows for
self-referral
Assess and identify level
of symptom severity,
symptom clusters, level
of functional impairment
Direct emerging adults to
needed services (FEMAP
or other) or reassure
them
Phase II
Provide treatment as
clinically indicated
Evaluate outcomes

Participation

Short term

Phase I
Emerging adults ages 16–
25 with concerns related
to mood or anxiety with
or without substance
use engage FEMAP
FEMAP staff provide assessment of emerging adults
with mental health and
substance use concerns
Phase II
Psychiatrists, psychologists, and addictions and
family therapists provide
treatment within a single
program
Patients complete
follow-up evaluations

Direct access of emerging
adults with signiﬁcant
mood or anxiety concerns to mental health
services, when they are
ready
Reduced usage of
emergency services as
ﬁrst point of contact for
psychiatric care
Shorter wait for needed
mental health services

METHODS
The Model
This study involved a cohort of emerging adults to evaluate
uptake, outputs, and medium-term outcomes of the program. The sample for this study was new and enrolled
subsequently to the previous study (9). The updated logic
model of the program is presented in Figure 1.
Participants
Emerging adults (ages 16–25) who contacted FEMAP between May 2013 and April 2015 and who met criteria by
telephone screen were scheduled for an in-person intake
interview. Research participation was essential for FEMAP
enrollment but was not required for continuation in the
program. Physician referral was not required for FEMAP
entry (9–11). Research inclusion and exclusion criteria were
identical to criteria for treatment at FEMAP. Individuals
with longer than 18 months lifetime medication treatment
were excluded to focus on the earlier stages of illness.
Youths with developmental delays, major medical problems,
and head trauma with unconsciousness lasting longer than a
few moments were excluded and referred to alternative
services. Individuals whose primary mental health concerns
appeared to be substance use, on the basis of the timing of
symptom onset, were referred to community addiction services and excluded. Individuals with substance use that
appeared to be secondary to mood and anxiety symptoms
ps.psychiatryonline.org

Reduced functional
impairment
Reduced mood or anxiety
symptoms
Reduced substance use
Improved quality of life
and health satisfaction
High satisfaction with
care

Long term
Fewer untreated emerging adults with mental
illness
Reduced school dropout
and unemployment
Reduced suicide
Reduced inpatient psychiatric service use
Reduced stigma, faster
recovery from mood
and anxiety disorders

Potential unintended consequences
Excessive use of psychiatric specialty services by individuals who are not ill enough to
warrant such services (cost implications)
With no referral by a primary care physician, FEMAP is left doing long-term care
(cost and capacity implications)

here evaluated uptake in an independent sample and investigated engagement and medium-term outcomes of the
program. We hypothesized that this youth-friendly, patientfocused model would provide appropriate inclusion and be
successful in meeting its early goals of keeping those most in
need engaged, reducing symptoms, and improving function
and quality of health and that the service would be rated as
satisfying by users.
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Outcomes and impact
Medium term

were included. Willing participants provided informed
consent after the study was fully explained, as approved by
the Human Research Ethics Board for the University of
Western Ontario, as per the Declaration of Helsinki.
Psychometric Measures
Demographic and other measures were administered in
person or occasionally by e-mail at the FEMAP intake interview (baseline) and included the Montgomery-Asberg
Depression Rating Scale, Self-Report (MADRS) (12); Anxiety
Sensitivity Index–Revised (ASI) (13); Sheehan Disability
Scale (SDS) (14); Trauma History Questionnaire (15); EuroQol
Group 5-Dimension Questionnaire, thermometer only (EQ-5D)
(16); and Inventory of College Students’ Recent Life Experiences (17), adjusted to ensure applicability to high school–age
populations. The Adolescent Alcohol and Drug Involvement
Scale screener (18, 19) was also administered.
At follow-up (see below), these questionnaires were
completed again, and an adjusted Patient Satisfaction Questionnaire (PSQ) (20) was also completed. The PSQ included
20 items, after it was adapted to a single-party payer and
emerging adults. The scale included questions about features
not applicable to many FEMAP patients (for example, questions about medication administration did not apply because
many of the emerging adults enrolled were not prescribed
medication; questions about parking did not apply to the
many emerging adults who used public transit). The three
questions deemed most speciﬁc to any model, by face validity,
were identiﬁed, and this subscale was reported along with
the total PSQ score. The three items were as follows: “I liked
the services I received here”; “If I had other choices, I would
still get services from this agency”; and “I would recommend
this agency to a friend or family member.” All referenced
measures except those created by the investigators had been
previously validated; several were modiﬁed as noted. All
multi-item scales evaluating a single construct showed
Cronbach’s alphas as reported in the tables.
Psychiatric Services 70:3, March 2019
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Treatment Model
FEMAP provides patient-centered treatment in a youthfriendly setting by using a multidisciplinary model that
is trauma informed and strength based. It utilizes standard
clinician training adjusted to patients’ needs and expressed
wishes and offers multiple therapeutic modalities, including psychopharmacology, cognitive-behavioral therapy, psychodynamic psychotherapy, addictions treatment, and group
therapy. Treatment is determined collaboratively with the
emerging adult, emphasizing patients’ individual needs
and wants and clinical considerations. The team includes
psychiatry, psychology, social work, addictions, and family
therapy. Licensed clinicians practice according to guidelines of their colleges and licensing organizations. Identiﬁcation of clinicians to work at FEMAP, including comfort
with the age of the population and the practice approach, is
by self-selection.
Participants completed research questionnaires at the
time of in-person intake (baseline) by FEMAP’s clinical social worker. Follow-up questionnaires were completed
between approximately 2 and 10 months after treatment
began, based on participants’ availability and willingness to
complete the questionnaires. Participants were given a $10
gift card to the movies for completion of the follow-up
questionnaires.

RESULTS

of the program name). Mean TABLE 1. Use of mental health
number of prior service care services before FEMAP
among 395 emerging
types engaged was 3.2 [see contact
adultsa
online supplement]. Fully
Service
N
%
77% of emerging adults had
Student
services
306
77
received help from a school
(high school,
mental health program, and
postsecondary)
73% had already been seen Primary care
290 73
in primary care for their
physician
mental health concerns. A Emergency
127 32
department visit
third (32%) had been to the
emergency department for Private mental health 114 29
professional
mental health concerns.
Outpatient hospital
115 29
Of the 398 emerging
service
adults with usable data from Crisis hotline
76 19
64 16
intake, 370 (92%) were eli- Psychiatric inpatient
unit
gible for the program and
Community mental
61 15
accepted and 28 (7%) were
health service
referred elsewhere (N=18) Internet support
49 12
or reassured that specialgroup
43 11
ized mental health care was Public health nurse
30
8
not necessary (N=10). A to- Crisis service (in
person)
tal of 323 (81%) contacted Religious counselor
20
5
the program without a Specialty mental
3
1
physician referral. Whether
health or addiction
service
or not the patient was referred by a physician was a FEMAP, First Episode Mood and Anxiety Program. The mean6SD numnot signiﬁcantly associated
ber of services used before FEMAP
with acceptance.
contact was 3.262.2 (median=3.0,
Data on preentry factors
mode=3).
of the 370 accepted participants are presented in
Table 2. Only 14% (N=51) were not either enrolled in school
or working. The group had clinically moderate levels of
depression, as indicated by MADRS mean scores (21), and
clinically signiﬁcant levels of dysfunction, as indicated by
SDS scores (22). The mean subjective rating on the EQ-5D
of satisfaction with the quality of health exceeded 2 SDs
below the norm for the 18–29 age group (23).
Substance use was low but present. Only 15% (N=55) of
369 entering participants with substance use data indicated
no alcohol use; almost 80% (N=291) used alcohol one or two
times per month or less. Fewer used drugs, including marijuana, with 46% (N=170) indicating no drug use and 72%
(N=265) reporting use one or two times per month or less
(including none).

Access and Pretreatment Factors
The ethnoracial backgrounds of those attending the intake
interview reﬂected the predominantly white Canadian and
European population of London, Ontario, at time of recruitment [see online supplement].
Services and number of service types sought by emerging adults prior to attending the FEMAP intake interview
are shown in Table 1. Only 5% (N=21) of participants who
attended the intake interview had not previously sought
mental health care (an indication of the euphemistic nature

Engagement
Approximately 676 emerging adults contacted FEMAP
during the time of recruitment. A total of 622 were eligible
for an intake, and 402 (65%) attended the intake [see ﬂowchart in the online supplement]. Of 370 eligible participants,
322 (87%) attended a clinical assessment but 71 (19%) disengaged either before this clinical assessment or immediately thereafter. Emerging adults who disengaged did not
differ signiﬁcantly in age, anxiety score, or quality of health

Statistical Analysis
All statistical analyses employed SPSS, version 25. Missing
items in a questionnaire were added by using multiple
imputations when they were #10% of total items and
missing at random. Questionnaire responses not meeting
these criteria were removed from individual analyses. Engagement with treatment was determined by chart review.
The general linear model was used for multivariate analyses.
The wait time for services after assessment for the patient
group in this study was not sufﬁciently long for participants
to serve as their own control. However, a post hoc comparison control group was created from a subsequent cohort of
individuals who were on a wait list for a mean of 3 months
between May 2015 and March 2017. There were no changes
in recruitment criteria between these two cohorts. [A ﬂowchart in an online supplement to this article illustrates the
recruitment process for both cohorts.]

Psychiatric Services 70:3, March 2019
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TABLE 2. Pre-entry characteristics of 370 emerging adults who were accepted into FEMAPa
Measure
Age
Montgomery-Asberg Depression Rating
Scaleb
Anxiety Sensitivity Indexc
Sheehan Disability Scaled
Total score
Days underfunctioning or lost per
week
EuroQol Group 5-Dimension
Questionnaire, thermometer onlye
Total N of types of traumatic eventsf
Inventory of College Students’ Recent
Life Experiencesg
Variable
Referred by a physician
Enrolled in school
Currently employed (full- or part-time)
Not in school and not working

Total N

M

SD

Median

Mode

370
370

19.2
12.3

2.6
4.5

18.0
12.0

370
367

55.7
17.4

31.9
7.2

52.0
18.0

360

4.3

2.5

5.0

369

61.4

16.9

65.0

50, 70

341
344

3.0
105.1

2.9
23.5

2.0
104.0

1
107

0–17
55–172

Total N

N

%

Median

Mode

Range

370
367
367
367

72
266
168
51

19
72
46
14

—
—
—
—

—
—
—
—

—
—
—
—

17
11
42, 44
21
7

Range
16–25
0–22.5
0–143
0–30
0–7
7–100

a

FEMAP, First Episode Mood and Anxiety Program. The 370 emerging adults included 249 females (67%) and 121 males (33%).
Possible scores on the nine-item scale range from 0 to 27, with higher scores indicating more severe depression. Cronbach’s a=.84.
c
Possible scores on the 36-item index range from 0 to 144, with higher scores indicating greater anxiety sensitivity. Cronbach’s a=.96.
d
Possible total scores range from 0 to 30, with higher scores indicating more functional impairment. Cronbach’s a=.81. Two items address days per week not
functioning (lost) or underfunctioning and were combined.
e
Possible scores range from 0–100; 100 indicates “the best health you can imagine.”
f
As measured by the Trauma History Questionnaire, a complex scale with scoring simpliﬁed to total number of types of lifetime traumatic events. Possible
scores range from 0 to 24.
g
Possible scores on the 47-item inventory range from 47 to 188, with higher scores indicating more severe daily hassles. Cronbach’s a=.93.
b

from those who were retained. In addition, neither sex nor
referral method was signiﬁcantly associated with disengagement. In a multivariate analysis, those who disengaged
were signiﬁcantly different from those who were retained
(F=2.38, df=6 and 358, p,0.03). Those who disengaged had
signiﬁcantly higher rates of street drug use (mostly marijuana) (mean6SD days of use in the past month=2.8062.56
versus 2.0062.36, p=0.01). In addition, those who disengaged had lower MADRS mean scores, indicating less
depression (11.3164.38 versus 12.4764.47, p=0.05), and
lower total SDS scores, indicating less functional impairment (15.8367.87 versus 17.6966.97, p=0.05), compared
with those who were retained. (Possible MADRS scores
range from 0 to 27, with higher scores indicating greater
depression. Possible SDS scores range from 0 to 30, with
higher scores indicating greater functional impairment.)
Follow-up data from all 370 accepted emerging adults
were pursued regardless of whether they disengaged. Mean
time from baseline to follow-up for the 174 patients (47%)
who completed follow-up questionnaires was 26.868.0
weeks (range 10.4 to 47 weeks). No individuals who disengaged completed follow-up data. Data for two individuals
were lost because of technical problems, and a third person
did not complete the SDS. Males were more likely than females not to complete the follow-up questionnaire (x2=3.25,
df=1, p=0.05, one-sided). Referral method was not signiﬁcantly associated with follow-up completion rates. A multivariate analysis indicated a trend for emerging adults who
214
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were lost to follow-up to be different from those retained
(p,0.08). Those not completing follow-up questionnaires
were younger (18.7062.20 years versus 19.5462.78 years,
p,0.01). However, no between-group differences were
found in depression, anxiety, functional impairment, or
quality-of-health satisfaction scores or substance use
ratings.
Intermediate Outcomes
From baseline to follow-up, symptom scores indicated signiﬁcant improvement (Table 3). Multivariate analysis conﬁrmed that the MADRS, ASI, SDS total score, and EQ-5D
all improved signiﬁcantly (F=31.42, df=4 and 158, p,0.001).
The change in MADRS score indicated a clinically signiﬁcant
improvement because the mean score dropped below 9 (24).
ASI scores and SDS scores improved, with the latter representing a clinically meaningful change, having dropped below
12 (22). General satisfaction with quality of health also
improved signiﬁcantly. Noteworthy was the wide range of
responses to treatment (Table 3). No signiﬁcant association
was found between the time between baseline and followup, which varied by participant from 2 to 10 months (mean=
6 months), and any outcome variable.
The post hoc analysis of data for persons in the wait list
control group involved 210 participants who waited 13.46
7.5 weeks (range 1–41.7) for assessment [see online supplement for scores]. Analyses of variance showed that the
treatment group had signiﬁcantly greater improvement in
Psychiatric Services 70:3, March 2019

OSUCH ET AL.

depression, as indicated by
MADRS scores (F=80.64,
df=1 and 383, p,0.001), as
well as improvements in
other areas as indicated by
ASI scores (F=32.81, df=1 and
373, p,0.001), and SDS
scores (F=52.61, df=1 and 376,
p,0.001). Again, no signiﬁcant association was found in
the control group between
the time from baseline to
follow-up, which varied by
participant, and any outcome
variable.
Patient Satisfaction
Patients completing followup data gave the service
high ratings, as indicated by
the PSQ total and subscale
scores (Table 3). On the full
scale, all but one participant
(99%) gave the program a
mean score more positive
than neutral. For the threequestion subscale, approximately 95% (N=163) rated
FEMAP more positive than
neutral, and 47% (N=91) of
participants gave it the highest possible score.

TABLE 3. Outcomes at medium-term follow-up for 174 emerging adults who completed follow-up
questionnaires after engaging with FEMAPa
Measure

Total N

Montgomery-Asberg Depression Rating
Scaleb
Score
Change in score

171

Anxiety Sensitivity Indexc
Score
Change in score

165

d

Sheehan Disability Scale
Total score
Change in total score

168

Days lost or underfunctioning per week
Change in N of days

157
154

EuroQol Group 5-Dimension
Questionnaire, thermometer onlye
Score
Change in score

171

Patient Satisfaction Questionnairef
Total score
Subscale score

171

SD

Range

Mean
improvement (%)

8.5
–4.0

5.4
5.4

0 to 25
–21 to 11

32

46.7
–11.1

32.2
26.4

0 to 144
–123 to 63

19

11.9
–6.3

7.8
7.4

0 to 30
–29 to 16

35

3.1
–1.4

2.6
2.9

0 to 7
–7 to 7

31

71.5
10.3

18.7
19.2

1 to 100
–55 to 70

17

84.7
13.3

9.8
2.0

58 to 100
6 to 15

na
na

a

FEMAP, First Episode Mood and Anxiety Program. The 174 emerging adults included 123 females (72%) and 49 males
(28%). The values for change in score and mean improvement indicate change from baseline. Except for the Patient
Satisfaction Questionnaire, which was not administered at baseline, all measures showed signiﬁcant improvement
(p,.001).
b
Possible scores on the nine-item scale range from 0 to 27, with higher scores indicating more severe depression.
Cronbach’s a=.93.
c
Possible scores on the 36-item index range from 0 to 144, with higher scores indicating greater anxiety sensitivity.
Cronbach’s a=.97.
d
Possible total scores range from 0 to 30, with higher scores indicating more functional impairment. Cronbach’s
a=.88. Two items address days per week not functioning or underfunctioning.
e
Possible scores range from 0–100; 100 indicates “the best health you can imagine.”
f
Possible total scores on the 20-item questionnaire range from 0 to 100, with higher scores indicating greater
satisfaction. Cronbach’s a=.83; mode=94. Possible scores on the three-item subscale range from 0–15, with higher
scores indicating greater satisfaction. Mode=15.

DISCUSSION
The results supported our hypotheses related to the logic
model of FEMAP. Age-appropriate specialty intervention
provided in the relatively early stages of illness, which
permitted self-referral, was successful in attracting and engaging appropriate patients without overinclusion. It was
associated with symptom reduction and improved functioning as well as enhanced quality of health at a mediumterm follow-up time point. Participants gave very positive
ratings to the service. In contrast, individuals in the wait list
control group showed signiﬁcantly less improvement in
symptoms and functional impairment. In addition, changes
in symptoms and functioning were not correlated with
the length of time between baseline and follow-up, which
varied by participant, suggesting that time was not an
overall factor in improvement. Although the ﬁndings were
of correlation and not causation, they support the hypothesis
that improvement at follow-up was a result of treatment.
Differences at baseline between males and females
were consistent with the epidemiology of mood and
anxiety disorders (25). Ethnoracial characteristics of the
Psychiatric Services 70:3, March 2019
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sample were consistent with the overall demographic
characteristics of the community where the program is located. Research in regions with other demographic characteristics is warranted.
Pretreatment data showed that participants had sought
help extensively from other sources before contacting
FEMAP, which reconﬁrmed that including “ﬁrst episode”
in the program’s name does not accurately reﬂect the population treated (9). Because most of the emerging adults came
to the program without a physician referral, the fact that they
had sought help elsewhere was unexpected but reassuring.
It is preferable that patients obtain care from more general
health services before receiving specialty care. More than
three-quarters of those who contacted FEMAP had seen a
school mental health care support person before seeking help
from FEMAP. Only 5% of those who contacted FEMAP reported that the FEMAP contact was their ﬁrst effort at help
seeking. Thus it is clear that the self-referral option did not
result in a large inﬂux of individuals who had not tried more
general health care services before seeking specialty care.
Almost a third of emerging adults who contacted FEMAP
had been seen in an emergency department before the
ps.psychiatryonline.org

215

PROCESS EVALUATION OF A TREATMENT PROGRAM FOR MOOD AND ANXIETY DISORDERS

FEMAP contact. Seeking help from an emergency department is not desirable; patients are best served at lower
cost in specialty ambulatory settings. Several factors could
contribute to seeking care in an emergency department,
including a lack of knowledge about available ambulatory
services; delays in help seeking resulting from stigma or a
lack of information (26, 27); and restrictions in ambulatory
services, including hours of operation, wait lists, and so
forth. To reduce mental health care costs and use of the
emergency department, efforts should be made to promote
ambulatory services and their capacity for rapid response.
Data collected at baseline showed that symptom severity
and functional impairment generally warranted clinical intervention (Table 2). Although most emerging adults were
either enrolled in school or working, they were either not
functioning or underfunctioning for approximately 4.3 days
per week. This represents a high-impact deﬁcit if allowed
to continue or worsen through lack of intervention and is
particularly detrimental at this life stage. Loss of school and
work time and of time spent in building relationships can
result in marked developmental impairment for emerging
adults (28). Treatment effectiveness and cost-effectiveness
of primary prevention across mental illnesses have been
difﬁcult to demonstrate (29, 30). Optimizing secondary
prevention with symptomatic emerging adults, the focus
of this model, may prove to be a wise use of health care
resources.
Among emerging adults scheduled for an in-person
FEMAP intake, 35% did not attend the intake appointment.
Understanding this disengagement is challenging because
the only available data for these individuals were from the
initial phone screen. Others have addressed some engagement issues among emerging adults (31). Collecting more
data during the FEMAP phone screen can aid understanding of early failure to engage in this setting.
Among eligible participants who attended the in-person
intake, 20% dropped out before attending either the ﬁrst
(13%) or second (7%) appointment with a treatment provider
[see online supplement]. Those who disengaged early had
signiﬁcantly more street drug use, compared with those
retained in the program, and showed a trend for less depression and less dysfunction. Disengagement in this instance could represent self-correction of overinclusion of
emerging adults in the program. At intake, those reporting
moderate to high substance use were educated by the intake
coordinator about their mental illness and told that a reduction in substance use would be a treatment recommendation. Individuals not interested in making such a change
may have decided to disengage—or they may have accepted
this advice, experienced improvements, and decided that
they no longer needed treatment. Further research can differentiate these possibilities; however, in both scenarios,
service uptake appeared to be reﬁned by self-selection of
those with greater motivation or need for treatment.
Individuals who disengaged early also had less severe
depression and dysfunction than those who were retained in
216
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the program, although the difference was not statistically
signiﬁcant in multivariate analysis. Nevertheless, this suggests some self-selection by those who were not as intensively in need of tertiary mental health services. Further
research should conﬁrm this trend before it is assumed that
the well-being of individuals who disengage early is of no
concern.
Participants completed follow-up questionnaires between
2 months and 10 months after program entry, depending on
their availability and willingness. Only 58% of those who
engaged with the program completed a follow-up questionnaire. Absence of follow-up data was more common among
males and younger participants. These ﬁndings may reﬂect
level of maturity, lower prioritization of mental health care
research, geographic instability, inability to ﬁnd transportation, or some other factor. It is noteworthy that individuals in the age cohort of FEMAP are often transient.
Emerging adults often left the area to attend school, and
others were only temporarily in the area to attend school.
The incentive to complete follow-up questionnaires was very
minimal in this study and, although research participation
was required for entry into clinical care, patients could opt
out at any time thereafter. Our follow-up rate was slightly
lower than that of a study of younger adolescents followed
for half as long (32).
Improvement in outcomes supported our hypotheses.
Depression and anxiety scores were both signiﬁcantly reduced at follow-up. The reduction in depression scores was
clinically signiﬁcant (24). Functional impairment improved
by a clinically meaningful amount, on average (22). The total SDS score fell by the largest percentage among the
measures used in the study (Table 3)—35% lower than
the initial score among those who completed follow-up. In
the time frame under study, anxiety and quality of health
were more resistant to change, but scores indicated signiﬁcant improvement.
Participants appeared highly satisﬁed with FEMAP. This
was particularly evident in responses to the PSQ subscale.
Over 90% of individuals gave positive ratings on this subscale and 47% gave the highest rating. Details about what
program participants found useful and challenging have
been published elsewhere (27, 33).
The study had several limitations. Rating scales were selfreport, presenting a limiting factor in interpreting results.
Findings were correlational, and causation cannot be concluded. The post hoc control group involved a wait list, and
thus the study did not demonstrate differences between
FEMAP and other evidence-based care. Nevertheless, another study that matched FEMAP patients with emerging
adults who were seeing physicians in Ontario but who were
not involved with FEMAP indicated that two logic model
short-term outcomes were met—faster access to specialty
mental health services and fewer emergency department
visits by FEMAP patients (34).
The wide range of changes between intake and follow-up
in the symptom, functioning, and quality-of-health scores is
Psychiatric Services 70:3, March 2019
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noteworthy. Many patients improved, even though some got
worse. This variability bears further investigation to determine moderators and mediators of response by subgroups
of patients in this setting. Future analysis of relationships
among preentry factors, treatment characteristics, and
follow-up outcomes may indicate key components that are
most helpful to emerging adults in their recovery.
CONCLUSIONS
This naturalistic evaluation of a program to treat mood and
anxiety disorders among emerging adults in the early stages
of illness examined uptake and engagement, preentry characteristics of participants, and medium-term outcomes, including symptom and functional improvement, quality of
health, and satisfaction with services. Statistically and clinically meaningful improvement was associated with participation, as was high satisfaction. This study demonstrated
the high potential of programs that offer personalized
treatment in a multidisciplinary model and standard clinician training adjusted to patients’ needs and expressed
wishes. The results of this study can provide valuable information for the development of mental health services
where they are most needed—for emerging adults with the
most common mental illnesses.
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